SCHEMBL344964

SCHEMBL344964

COc1ccc(CCCC(=O)O)cc1F

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.54
PPARA Q07869 1/20 0.54
SELP P16109 1/20 0.53
HTT P42858 2/20 0.51
LMNA P02545 1/20 0.51
MAPK1 P28482 1/20 0.51
RAB9A P51151 1/20 0.51
KDM4E B2RXH2 1/20 0.51
MITF O75030 1/20 0.51
ALDH1A1 P00352 1/20 0.51
FFAR1 O14842 1/20 0.51
FFAR4 Q5NUL3 1/20 0.51
CYP1A2 P05177 1/20 0.49
PLAAT3 P53816 1/20 0.48
PLAAT5 Q96KN8 1/20 0.48
PLAAT2 Q9NWW9 1/20 0.48
PLAAT4 Q9UL19 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL585819 0.91 FFAR4 (0.60) PPARAHTTLMNAMAPK1RAB9A
SCHEMBL17361774 0.88 SELP (0.53) PPARGPPARASELPFFAR1FFAR4
SCHEMBL30558401 0.88 SELP (0.53) PPARGPPARASELPFFAR1FFAR4
Malonic Acid SCHEMBL8557894 0.87 FFAR1 (0.56) PPARAHTTLMNAMAPK1RAB9A
SCHEMBL503571 0.86 PLAAT3 (0.61) PPARGPPARASELPRAB9AKDM4E
SCHEMBL8984890 0.84 SELP (0.55) PPARGPPARASELPMAPK1RAB9A
SCHEMBL7286269 0.84 ALDH1A1 (0.57) LMNAALDH1A1
SCHEMBL6137035 0.84 HTT (0.50) HTTLMNAMAPK1RAB9AKDM4E
SCHEMBL1453516 0.83 HPGD (0.66) PPARGPPARASELPLMNAFFAR1
SCHEMBL22010379 0.83 SELP (0.54) PPARGPPARASELPMAPK1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243334-A1 SUBSTITUTED HYDOXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-28 US disclosed
WO-2012012320-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENIUM PHARMACEUTICALS, INC. (US) 2012-01-26 WO disclosed
US-20120015942-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-19 US disclosed
US-20120015942-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-19 US disclosed
US-20120015942-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015942-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, HDAC2 PPARG 1430/4885PPARA 901/4885SELP 3319/4885
US-20140243334-A1 SUBSTITUTED HYDOXAMIC ACIDS AND USES THEREOF HDAC6, H1-3, H1-5 PPARG 1447/4885PPARA 743/4885SELP 3936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.